Kawada, Toru
Fukumitsu, Masafumi
Matsushita, Hiroki
Yoshida, Yuki
Sato, Kei
Morita, Hidetaka
Nishikawa, Takuya
Suehara, Satoru
Sawada, Satoshi
Saku, Keita
Article History
Received: 17 May 2024
Revised: 31 July 2024
Accepted: 15 August 2024
First Online: 11 September 2024
Compliance with ethical standards
:
: Toru Kawada received a consulting fee from NTT Research, Inc. Keita Saku received research funding from Abiomed Japan K.K., NTT Research, Inc., Asahi Kasei ZOLL Medical Corporation, Neuroceuticals, Inc., and Zeon Medical, Inc., and honoraria from Abiomed Japan K.K. and Mallinckrodt Pharmaceuticals, Inc. Other authors declare no conflict of interest.
: This study did not involve human participants. The Animal Subject Committee at the National Cerebral and Cardiovascular Center has approved the animal experiments.
: Male SHR, purchased from Japan SLC, were cared for in strict compliance with the Guiding Principles for the Care and Use of Animals in the Field of Physiological Sciences, which the Physiological Society of Japan has approved. The Animal Subjects Committee at the National Cerebral and Cardiovascular Center reviewed and approved all experimental protocols (21009, 22033, 23013).